{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:49:11Z","timestamp":1794084551727,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Foster"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["556416293"],"award-info":[{"award-number":["556416293"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Federal Ministry of Research, Technology and Space and co-funded by the European Commission","award":["01KT2304B"],"award-info":[{"award-number":["01KT2304B"]}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Research, Technology and Space","doi-asserted-by":"crossref","award":["03ZU2111AB"],"award-info":[{"award-number":["03ZU2111AB"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Strategic Initiative DKTK Organoid Platform"},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Federal Ministry of Education and Research","award":["Advanced Clinician Scientist Program CAMINO"],"award-info":[{"award-number":["Advanced Clinician Scientist Program CAMINO"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Macrophages are among the most abundant immune cells in the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME) and play a key role in regulating the immunosuppressive niche that facilitates tumor growth. Although recent three-dimensional (3D) culture systems using patient-derived materials have advanced our understanding of tumor biology, most models lack key cellular TME components and thus fail to capture tumor-immune cell interactions. To address this gap, we developed an in-vitro 3D co-culture model incorporating PDAC patient-derived organoids (PDOs) and macrophages within a synthetic hydrogel matrix. We optimized culture conditions by tuning medium and matrix conditions to support both cell lineages. Flow cytometry and transcriptomic analyses revealed that initially undifferentiated macrophages adopt an M2-like profile upon exposure to PDAC PDOs in starPEG-heparin hydrogels, mirroring the macrophage phenotypes observed by multiplex immunohistochemistry in the matched primary PDAC tissues. Cytokine secretome profiling revealed PDO-specific differences, indicating distinct underlying macrophage polarization subtypes. Collectively, our starPEG-heparin hydrogel-based 3D co-culture enables hypothesis-driven and physiologically relevant studies of tumor-macrophage interactions and may advance immune-modulatory treatment strategies in patients with PDAC.<\/jats:p>","DOI":"10.1038\/s41698-026-01678-6","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:04:55Z","timestamp":1788620695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions"],"prefix":"10.1038","volume":"10","author":[{"given":"Julius","family":"Thyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor A.","family":"Sioson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Haak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Jahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Fusenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul M.","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Stammberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Br\u00fcckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Polster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena J.","family":"Kast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Prause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Mittn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin H.","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian M.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Aust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Loessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Stange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Poetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Pecqueux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Baenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"1678_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1678_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1678_CR3","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi, J. D., Surana, R., Valle, J. W. & Shroff, R. T. Pancreatic cancer. Lancet 395, 2008\u20132020 (2020).","journal-title":"Lancet"},{"key":"1678_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa, T., Wood, L. D., Itoi, T. & Takaori, K. Pancreatic cancer. Lancet 388, 73\u201385 (2016).","journal-title":"Lancet"},{"key":"1678_CR5","doi-asserted-by":"publisher","first-page":"1287459","DOI":"10.3389\/fimmu.2024.1287459","volume":"15","author":"C Hartupee","year":"2024","unstructured":"Hartupee, C. et al. Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target. Front. Immunol 15, 1287459 (2024).","journal-title":"Front. Immunol"},{"key":"1678_CR6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41591-022-01829-9","volume":"28","author":"LJ Padr\u00f3n","year":"2022","unstructured":"Padr\u00f3n, L. J. et al. Sotigalimab and\/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial. Nat. Med. 28, 1167\u20131177 (2022).","journal-title":"Nat. Med."},{"key":"1678_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park, W., Chawla, A. & O\u2019Reilly, E. M. Pancreatic Cancer. JAMA 326, 851 (2021).","journal-title":"JAMA"},{"key":"1678_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324\u2013338 (2015).","journal-title":"Cell"},{"key":"1678_CR9","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/nm.3973","volume":"21","author":"L Huang","year":"2015","unstructured":"Huang, L. et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat. Med. 21, 1364\u20131371 (2015).","journal-title":"Nat. Med."},{"key":"1678_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/path.5906","volume":"257","author":"A Hennig","year":"2022","unstructured":"Hennig, A. et al. Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment. J. Pathol 257, 607\u2013619 (2022).","journal-title":"J. Pathol"},{"key":"1678_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak, R., Zhang, E. T. & Kuo, C. J. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat. Rev. Cancer 24, 523\u2013539 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1678_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 29, 725\u2013738 (2019).","journal-title":"Cell Res."},{"key":"1678_CR13","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/gutjnl-2015-309193","volume":"65","author":"G Di Caro","year":"2016","unstructured":"Di Caro, G. et al. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Gut. 65, 1710\u20131720 (2016).","journal-title":"Gut."},{"key":"1678_CR14","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1089\/ars.2012.4834","volume":"18","author":"A Etzerodt","year":"2013","unstructured":"Etzerodt, A. & Moestrup, S. K. CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects. Antioxid. Redox Signal. 18, 2352\u20132363 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"1678_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41568-021-00375-9","volume":"21","author":"SA Kerk","year":"2021","unstructured":"Kerk, S. A., Papagiannakopoulos, T., Shah, Y. M. & Lyssiotis, C. A. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment. Nat. Rev. Cancer 21, 510\u2013525 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1678_CR16","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia, C. J. et al. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Gastroenterology 162, 2018\u20132031 (2022).","journal-title":"Gastroenterology"},{"key":"1678_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-Associated Macrophages: From Mechanisms to Therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"1678_CR18","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.2147\/CMAR.S196951","volume":"11","author":"M Yu","year":"2019","unstructured":"Yu, M. et al. Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis. Cancer Manag. Res. 11, 4041\u20134058 (2019).","journal-title":"Cancer Manag. Res."},{"key":"1678_CR19","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/bjc.1998.280","volume":"77","author":"M Koukourakis","year":"1998","unstructured":"Koukourakis, M. et al. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br. J. Cancer 77, 1696\u20131703 (1998).","journal-title":"Br. J. Cancer"},{"key":"1678_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.105067","volume":"71","author":"Y Shafran","year":"2021","unstructured":"Shafran, Y. et al. Co-culture hydrogel micro-chamber array-based plate for anti-tumor drug development at single-element resolution. Toxicol. Vitr. 71, 105067 (2021).","journal-title":"Toxicol. Vitr."},{"key":"1678_CR21","doi-asserted-by":"publisher","first-page":"217106","DOI":"10.1016\/j.canlet.2024.217106","volume":"598","author":"R Yang","year":"2024","unstructured":"Yang, R. et al. Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids. Cancer Lett. 598, 217106 (2024).","journal-title":"Cancer Lett."},{"key":"1678_CR22","doi-asserted-by":"publisher","first-page":"e17390","DOI":"10.1002\/adma.202517390","volume":"38","author":"A Nadernezhad","year":"2026","unstructured":"Nadernezhad, A. et al. Bottom-Up Programming of Cell States in Cancer Organoids with Defined Synthetic Adhesion Cues. Adv. Mater 38, e17390 (2026).","journal-title":"Adv. Mater"},{"key":"1678_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","volume":"5","author":"EA Aisenbrey","year":"2020","unstructured":"Aisenbrey, E. A. & Murphy, W. L. Synthetic alternatives to Matrigel. Nat. Rev. Mater. 5, 539\u2013551 (2020).","journal-title":"Nat. Rev. Mater."},{"key":"1678_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41563-021-01085-1","volume":"21","author":"CR Below","year":"2022","unstructured":"Below, C. R. et al. A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids. Nat. Mater. 21, 110\u2013119 (2022).","journal-title":"Nat. Mater."},{"key":"1678_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41578-023-00535-3","volume":"8","author":"R Curvello","year":"2023","unstructured":"Curvello, R., Kast, V., Ord\u00f3\u00f1ez-Mor\u00e1n, P., Mata, A. & Loessner, D. Biomaterial-based platforms for tumour tissue engineering. Nat. Rev. Mater 8, 314\u2013330 (2023).","journal-title":"Nat. Rev. Mater"},{"key":"1678_CR26","doi-asserted-by":"publisher","first-page":"2201907","DOI":"10.1002\/adhm.202201907","volume":"12","author":"V Kast","year":"2023","unstructured":"Kast, V. et al. A Tumor Microenvironment Model Of Pancreatic Cancer To Elucidate Responses Toward Immunotherapy. Adv. Healthc. Mater 12, 2201907 (2023).","journal-title":"Adv. Healthc. Mater"},{"key":"1678_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501 (2015).","journal-title":"Nature"},{"key":"1678_CR28","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.62347\/BQFH7352","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu, J. In vitro co-culture models for studying organoids-macrophages interaction: the golden technology of cancer immunotherapy. Am. J. Cancer Res. 14, 3222\u20133240 (2024).","journal-title":"Am. J. Cancer Res."},{"key":"1678_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","volume":"11","author":"JL Chitty","year":"2025","unstructured":"Chitty, J. L. & Cox, T. R. The extracellular matrix in cancer: from understanding to targeting. Trends Cancer 11, 839\u2013849 (2025).","journal-title":"Trends Cancer"},{"key":"1678_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40425-019-0622-0","volume":"7","author":"B Benner","year":"2019","unstructured":"Benner, B. et al. Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro. J. Immunother. Cancer 7, 140 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"1678_CR31","doi-asserted-by":"publisher","first-page":"104932","DOI":"10.1016\/j.cellimm.2025.104932","volume":"409\u2013410","author":"KW Antonsen","year":"2025","unstructured":"Antonsen, K. W. et al. In vitro ovarian tumor-conditioned CD163+ human macrophages retain phagocytic response to CD47 blockade. Cell. Immunol. 409\u2013410, 104932 (2025).","journal-title":"Cell. Immunol."},{"key":"1678_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-physiol-020518-114515","volume":"81","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Crawford, H. C. & Pasca di Magliano, M. Epithelial-Stromal Interactions in Pancreatic Cancer. Annu. Rev. Physiol. 81, 211\u2013233 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"1678_CR33","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41551-025-01417-5","volume":"9","author":"K Liu","year":"2025","unstructured":"Liu, K. et al. Macrophage-augmented organoids recapitulate the complex pathophysiology of viral diseases and enable development of multitarget therapeutics. Nat. Biomed. Eng. 9, 1848\u20131868 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"1678_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature20168","volume":"539","author":"N Gjorevski","year":"2016","unstructured":"Gjorevski, N. et al. Designer matrices for intestinal stem cell and organoid culture. Nature 539, 560\u2013564 (2016).","journal-title":"Nature"},{"key":"1678_CR35","doi-asserted-by":"publisher","first-page":"2004705","DOI":"10.1002\/advs.202004705","volume":"8","author":"DR Hunt","year":"2021","unstructured":"Hunt, D. R. et al. Engineered Matrices Enable the Culture of Human Patient-Derived Intestinal Organoids. Adv. Sci. 8, 2004705 (2021).","journal-title":"Adv. Sci."},{"key":"1678_CR36","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41563-024-01908-x","volume":"23","author":"BL LeSavage","year":"2024","unstructured":"LeSavage, B. L. et al. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Nat. Mater. 23, 1138\u20131149 (2024).","journal-title":"Nat. Mater."},{"key":"1678_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.actbio.2022.04.031","volume":"163","author":"PV Taufalele","year":"2023","unstructured":"Taufalele, P. V. et al. Matrix stiffness enhances cancer-macrophage interactions and M2-like macrophage accumulation in the breast tumor microenvironment. Acta Biomater. 163, 365\u2013377 (2023).","journal-title":"Acta Biomater."},{"key":"1678_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04810-3","volume":"22","author":"J Xiong","year":"2024","unstructured":"Xiong, J. et al. Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. J. Transl. Med. 22, 85 (2024).","journal-title":"J. Transl. Med."},{"key":"1678_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-026-02681-y","volume":"25","author":"SP Jeevanandan","year":"2026","unstructured":"Jeevanandan, S. P. et al. Advanced 3D cancer models for analyzing tumor-immune cell interaction and therapeutic response. Mol. Cancer 25, 132 (2026).","journal-title":"Mol. Cancer"},{"key":"1678_CR40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","volume":"1","author":"NG Steele","year":"2020","unstructured":"Steele, N. G. et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat. Cancer 1, 1097\u20131112 (2020).","journal-title":"Nat. Cancer"},{"key":"1678_CR41","doi-asserted-by":"publisher","first-page":"112620","DOI":"10.1016\/j.celrep.2023.112620","volume":"42","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation. Cell Rep. 42, 112620 (2023).","journal-title":"Cell Rep."},{"key":"1678_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cjp2.192","volume":"7","author":"AJ McGuigan","year":"2021","unstructured":"McGuigan, A. J. et al. Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. J. Pathol. Clin. Res. 7, 99\u2013112 (2021).","journal-title":"J. Pathol. Clin. Res."},{"key":"1678_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55424-2","volume":"16","author":"S Sivakumar","year":"2025","unstructured":"Sivakumar, S. et al. Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms. Nat. Commun. 16, 1397 (2025).","journal-title":"Nat. Commun."},{"key":"1678_CR44","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y. et al. CSF1\/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models. Cancer Res. 74, 5057\u20135069 (2014).","journal-title":"Cancer Res."},{"key":"1678_CR45","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-20-0099","volume":"26","author":"ZA Wainberg","year":"2020","unstructured":"Wainberg, Z. A. et al. Open-label, Phase I Study of Nivolumab Combined with nab -Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer. Clin. Cancer Res. 26, 4814\u20134822 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1678_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening, T. M. et al. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 17, 651\u2013662 (2016).","journal-title":"Lancet Oncol."},{"key":"1678_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora, M. et al. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy. Cell 182, 886\u2013900.e17 (2020).","journal-title":"Cell"},{"key":"1678_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal, A. A. et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572, 392\u2013396 (2019).","journal-title":"Nature"},{"key":"1678_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23482-5","volume":"12","author":"H Atcha","year":"2021","unstructured":"Atcha, H. et al. Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing. Nat. Commun. 12, 3256 (2021).","journal-title":"Nat. Commun."},{"key":"1678_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.actbio.2019.02.048","volume":"89","author":"R Sridharan","year":"2019","unstructured":"Sridharan, R., Cavanagh, B., Cameron, A. R., Kelly, D. J. & O\u2019Brien, F. J. Material stiffness influences the polarization state, function and migration mode of macrophages. Acta Biomater. 89, 47\u201359 (2019).","journal-title":"Acta Biomater."},{"key":"1678_CR51","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac, H. et al. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 8, 1112\u20131129 (2018).","journal-title":"Cancer Discov."},{"key":"1678_CR52","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887\u2013904 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1678_CR53","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep 7, 16878 (2017).","journal-title":"Sci. Rep"},{"key":"1678_CR54","doi-asserted-by":"crossref","unstructured":"Schmidt, U., Weigert, M., Broaddus, C. & Myers, G. Cell detection with star-convex polygons. in Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) Vol. 11071 LNCS (2018).","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"1678_CR55","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1091\/mbc.E24-06-0241","volume":"36","author":"SRS Varady","year":"2025","unstructured":"Varady, S. R. S., Greiner, D. & Roh-Johnson, M. Macrophage subtypes inhibit breast cancer proliferation in culture. Mol. Biol. Cell. 36, 36 (2025).","journal-title":"Mol. Biol. Cell."},{"key":"1678_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-017-0654-6","volume":"37","author":"J-H Lee","year":"2018","unstructured":"Lee, J.-H. et al. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. J. Exp. Clin. Cancer Res. 37, 4 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1678_CR57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13046-024-03201-w","volume":"43","author":"J Tao","year":"2024","unstructured":"Tao, J. et al. CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment. J. Exp. Clin. Cancer Res. 43, 277 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1678_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06867-5","volume":"20","author":"KJ Norberg","year":"2020","unstructured":"Norberg, K. J. et al. A novel pancreatic tumour and stellate cell 3D co-culture spheroid model. BMC Cancer 20, 475 (2020).","journal-title":"BMC Cancer"},{"key":"1678_CR59","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cells14060450","volume":"14","author":"R Verloy","year":"2025","unstructured":"Verloy, R. et al. Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation. Cells 14, 450 (2025).","journal-title":"Cells"},{"key":"1678_CR60","unstructured":"Carpentier, G. & Henault, E. Protein Array Analyzer for ImageJ. http:\/\/image.bio.methods.free.fr (2010)."},{"key":"1678_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01678-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01678-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:02:23Z","timestamp":1788681743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01678-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01678-6","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"343"}}